Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Distribution of EGFR R521K Polymorphism in Different Iranian Ethnic Groups

Asal Shahrokhshahi 1 and Massoud Houshmand 2 , *
Authors Information
1 Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, IR Iran
2 Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: 18 (4); e6438
  • Published Online: April 27, 2016
  • Article Type: Short Communication
  • Received: September 29, 2015
  • Accepted: December 12, 2015
  • DOI: 10.17795/zjrms-6438

To Cite: Shahrokhshahi A, Houshmand M. Distribution of EGFR R521K Polymorphism in Different Iranian Ethnic Groups, Zahedan J Res Med Sci. Online ahead of Print ; 18(4):e6438. doi: 10.17795/zjrms-6438.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis. 2008; 23(7): 683-8[DOI][PubMed]
  • 2. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H. Five common cancers in Iran. Arch Iran Med. 2010; 13(2): 143-6[PubMed]
  • 3. Satia-Abouta J, Galanko JA, Potter JD, Ammerman A, Martin CF, Sandler RS, et al. Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol. 2003; 158(10): 951-62[PubMed]
  • 4. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009; 22(4): 191-7[DOI][PubMed]
  • 5. Davies RL, Grosse VA, Kucherlapati R, Bothwell M. Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7. Proc Natl Acad Sci U S A. 1980; 77(7): 4188-92[PubMed]
  • 6. Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PJ. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol. 2002; 29(1 Suppl 4): 3-14[PubMed]
  • 7. Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006; 7(7): 505-16[DOI][PubMed]
  • 8. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008; 358(11): 1160-74[DOI][PubMed]
  • 9. Sato JD, Kawamoto T, Le AD, Mendelsohn J, Polikoff J, Sato GH. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med. 1983; 1(5): 511-29[PubMed]
  • 10. Moriai T, Kobrin MS, Korc M. Cloning of a variant epidermal growth factor receptor. Biochem Biophys Res Commun. 1993; 191(3): 1034-9[DOI][PubMed]
  • 11. Moriai T, Kobrin MS, Hope C, Speck L, Korc M. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Proc Natl Acad Sci U S A. 1994; 91(21): 10217-21[PubMed]
  • 12. Lurje G, Nagashima F, Zhang W, Yang D, Chang HM, Gordon MA, et al. Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab. Clin Cancer Res. 2008; 14(23): 7884-95[DOI][PubMed]
  • 13. Wang WS, Chen PM, Chiou TJ, Liu JH, Lin JK, Lin TC, et al. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin Cancer Res. 2007; 13(12): 3597-604[DOI][PubMed]
  • 14. Hsieh YY, Tzeng CH, Chen MH, Chen PM, Wang WS. Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy. Cancer Sci. 2012; 103(4): 791-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments